Flow cytometric analysis of Jurkat (Human T cell leukemia T lymphocyte, Left) / U266B1 (Human multiple myeloma B lymphocyte, Right) labelling Human CD70 antibody at 1/200 dilution (1 μg) / (Red) compared with a Mouse IgG1, κ monoclonal IgG (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti - Mouse IgG Alexa Fluor® 647 was used as the secondary antibody.
Negative control: Jurkat
Product Details
Product Details
Product Specification
Host | Mouse |
Antigen | CD70 |
Synonyms | CD70 antigen; CD27 ligand (CD27-L); Tumor necrosis factor ligand superfamily member 7Imported; CD27L; CD27LG; TNFSF7 |
Location | Cell membrane |
Accession | P32970 |
Clone Number | S-2898 |
Antibody Type | Mouse mAb |
Isotype | IgG3,k |
Application | FCM |
Reactivity | Hu |
Positive Sample | U266B1 |
Purification | Protein A |
Concentration | 2 mg/ml |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS pH7.4 |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied. |
Dilution
application | dilution | species |
FCM | 1:200 | Hu |
Background
CD70, also known as CD27 ligand, is a type Ⅱ transmembrane protein that plays a crucial role in the immune system. It is primarily expressed on antigen - presenting cells (APCs) such as dendritic cells, macrophages, and B cells, as well as on activated T cells. CD70 interacts with its receptor CD27, which is mainly found on T cells, B cells, and natural killer (NK) cells. This interaction provides important co - stimulatory signals that promote T cell activation, proliferation, and differentiation, and also enhances B cell and NK cell functions. Additionally, CD70 is involved in the regulation of immune responses, including the maintenance of immune homeostasis and the induction of immune - mediated tumor cell killing. Abnormal expression of CD70 has been associated with various diseases, such as autoimmune disorders and certain types of cancers. Therefore, CD70 is considered a promising target for the development of immunotherapies.
Picture
Picture
FC
